Course Description

Breast cancer is one of the most challenging problem worldwide. This Course is dedicated to an indepth discussion of the best care options for the comprehensive management of patients with breast cancer.
The educational program is directed primarily toward medical
oncologists, breast surgeons, breast radiologists, and fellows
interested in breast cancer.
The format of the course will include didactic sessions from a
panel of expert scientists who will also discuss emerging methods for subtyping breast cancer and predict response to primary chemotherapy, question-and-answer panel discussion, and time for participant to interact with faculty.
We do hope that participants will remember this Course of the Mediterranean School of Oncology as a highlight of up-to-date
training in the field of breast cancer.

FRIDAY, May 25

10.30 – 13.00 Early Breasy Cancer
Aromatase inhibitor therapy for early breast cancer: A review of the most recent data
( G. Mustacchi, Trieste ) go to slides

Targeted adjuvant systemic therapy: current status and future directions of Trastuzumab
( G. Tonini, Rome ) go to slides

Novel trials with multitargeted tyrosine kinase inhibitors
( G. Tortora, Naples ) go to slides

Taxane- vs anthracycline-containing chemotherapy in the treatment of early breast cancer and the issue of cardiac toxicity
( V. Adamo, Messina - E.Salvatorelli, Chieti-Pescara ) go to slides

13.00 – 14.00 LUNCH

14.00 – 15.30 Advances in tumor imaging

Surveillance of BRCA1 and BRCA2 mutation carriers with Magnetic Resonance Imaging, ultrasound, mammography, and clinical breast examination
( S. Corcione, Ferrara ) go to slides

The role of MRI in the selection of patients for breast conservation
( V. Fiaschetti, Rome ) go to slides

15.30 – 17.00 Case presentation with audience participation and polling
( P. Marchetti, Rome – G. Mustacchi, Trieste – C. Natoli, Chieti-Pescara )
go to slides (M. Zilli, Chieti) go to slides (A. Di Giacobbe, Chieti) go to slides (S. Gildetti, Chieti)
go to slides (J. Giampietro, Chieti)

SATURDAY, May 26

9.00 - 9.30
Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer and the issue of fertility preservation: still a question?
( C. Natoli, Chieti-Pescara ) go to slides

9.30 – 10.30 Advanced Breast Cancer

Bone metastasis: from bench to bedside
( A. Teti, L’Aquila - P. Marchetti, Rome ) go to slides

Optimal sequence of hormonotherapy in advanced breast cancer
(P. Pronzato, Genoa ) go to slides

10.30 – 12.00

Breast cancer gene and protein expression profiling
The impact of gene signatures on disease characterization and clinical outcomes
( A. Weisz, Naples ) go to slides

Genomic and proteomic predictors of sensitivity to preoperative chemotherapy
( S. Iacobelli, Chieti-Pescara ) go to slides

12.15 - 12.30 General Discussion & Conclusion

FACULTY

V. Adamo
University of Messina
Messina

S. Corcione
University of Ferrara
Ferrara

V. Fiaschetti
University of Tor Vergata
Rome

S. Iacobelli
University “ G. D’Annunzio”
Chieti- Pescara

P. Marchetti
Sant’Andrea Hospital
Rome

G. Mustacchi
University of Trieste
Trieste

C. Natoli
University “ G. D’Annunzio”
Chieti- Pescara

P. Pronzato
National Cancer Institute
Genoa

E.Salvatorelli
University “ G. D’Annunzio”
Chieti- Pescara

A.M. Teti
University of L’Aquila
L’Aquila

G. Tonini
University Campus BioMedico
Rome

G. Tortora
University “Federico II”
Naples

A. Weisz
II University of Naples
Naples